Skip to main content

Table 4 Patients with manifest cardiovascular diseases

From: From hypertension control to global cardiovascular risk management: an educational intervention in a cluster-randomised controlled trial

  Complex intervention A n = 327 Simple intervention B n = 279 A vs. B
  Mean FU 95% CI Mean FU 95% CI Difference/Odds ratio 95% CI p ICC p
RR systolic [mmHg] 134.3 132.5-136.1 133.8 131.8-135.7 Δ = 0.5 -2.2-3.2 0.698 0.033 0.080
RR diastolic [mmHg] 78.1 77.0-79.2 79.1 77.9-80.2 Δ = -1.0 -2.5-0.6 0.243 0.048 0.020
Control rate RR < 140/90 59.2% 52.7%-65.7% 56.9% 49.9%-63.8% OR = 1.11 0.73-1.70 0.632 0.076 0.015
Control rate RR < 160/95 90.2% 86.4%-93.9% 88.9% 84.7%-93.1% OR = 1.15 0.66-1.99 0.623 0.037 0.280
Cholesterol [mg/dl] 197.8 194.1-201.6 199.8 195.8-203.9 Δ = -2.0 -7.6-3.6 0.482 0.000 1.000
Current smoker 15.2% 11.2%-19.1% 19.2% 15.1%-23.2% OR = 0.57 0.26-1.26 0.163 0.258 0.005
ASS 73.0% 69.2%-76.7% 73.3% 69.3%-77.2% OR = 0.96 0.46-2.01 0.917 0.230 <0.001
Statins 64.1% 57.2%-71.0% 48.2% 39.7%-56.7% OR = 2.64 1.35-5.16 0.005 0.280 <0.001
  1. Outcomes at follow up in subpopulation at high CVR (10-year mortality ≥ 5%), but no manifest CVD (complete cases), adjusted for baseline and taking cluster effects into account by use of a mixed model.